Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
GRAL
GRAL
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
GRAL News
Hims & Hers Super Bowl Ad Sparks Controversy Over Cancer Test
6d ago
Benzinga
Hims & Hers Introduces New Cancer Test, But It Might Not Be Fully Prepared for Use.
Feb 06 2026
Barron's
Hims & Hers Launches Multi-Cancer Early Detection Test
Feb 04 2026
seekingalpha
GRAIL Submits FDA Application to Advance Early Cancer Detection
Jan 30 2026
PRnewswire
GRAIL Submits FDA Application to Advance Early Cancer Detection
Jan 30 2026
Newsfilter
2025 IPO Class: 3 Stocks Showing Positive Chart Trends
Jan 23 2026
Barron's
Tesla Rallies on Major Self-Driving Robotaxi News
Jan 23 2026
Yahoo Finance
Grail (GRAL) Shares Surge 13.53% Amid 2026 Optimism
Jan 22 2026
Fool
Eagle Bancorp Reports Q4 Earnings Beat, Shares Surge 19.8%
Jan 22 2026
Benzinga
Gradalis Reports Vigil Therapy Significantly Extends Ovarian Cancer Patient Survival
Jan 14 2026
Globenewswire
Healthcare Sector Outperforms S&P 500 with 12.52% Gain and 3.20 Health Score
Jan 14 2026
seekingalpha
Grail (GRAL) Issues 2025 Revenue Guidance of $147M-$148M, Exceeding Consensus
Jan 14 2026
seekingalpha
GRAIL Inc (GRAL) Stock Surpasses Analyst Target Price of $105
Jan 13 2026
NASDAQ.COM
GRAIL to Present Early Cancer Detection Technology at J.P. Morgan Healthcare Conference
Dec 15 2025
PRnewswire
Abbott Set to Purchase Exact Sciences for $21 Billion
Nov 20 2025
WSJ
GRAIL to Present at Piper Sandler 37th Annual Healthcare Conference
Nov 18 2025
PRnewswire
Show More News
